Your device is not supported to view the app, please use landscape view or screen 320px or more.

 
 
 
 
 

Lynch Syndrome & Molecular Pathology: NICE Guidelines

Bringing molecular pathology into everyday practice (2 dates available)

Who should attend:This half day workshop is aimed at oncologists, consultants and SpR’s,specialist nurses treating patients with bowel cancer or those who are beinginvestigated for bowel cancer.

Aims:

  • To understand the NICE diagnostic guidance DG27 (nice.org.uk/guidance/dg27)
  • To understand the clinical benefits of the NICE guidance
  • To understand the limitations of the required molecular pathology techniques
  • To understand how results are interpreted
  • To understand the importance of taking appropriate informed consent
  • To understand the wider implications of adopting molecular pathology for theinvestigation and management of patients with cancer

Outcomes:

  • Attendees should be able to understand the NICE diagnostic guidelines DG27
  • Attendees should be able to explain these new testing strategies for patients
  • Attendees should be able to understand the different treatment options available topatients with advanced bowel cancer who have mutations in KRAS
  • Attendees should have an understanding of Lynch syndrome and its implicationsfor the patient and their family
  • Attendees should have an awareness of how the NICE guidance is going to changetheir clinical practice
The day is accredited with the RCP for 2.5 CPD points/hours

Regsiter here or if you require an invoice raising please contact joanne.king15@nhs.net or ring 0151 802 5010.

Price: £40 or £20 (LHP only).


« View all events